APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurological Biomarkers

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.

Selected research

Market Analysis & Forecast

Global Neurological Biomarkers Market Analysis and Forecast 2026-2032

21 December 2025208 pages

Choose your research edition.

Industry ResearchNeurological Biomarkers Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurological Biomarkers Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Neurological Biomarkers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurological Biomarkers Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurological Biomarkers Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.

Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.

North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.

Read the full market overview

In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.

This report presents an overview of global market for Neurological Biomarkers, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neurological Biomarkers, also provides the sales of main regions and countries. Of the upcoming market potential for Neurological Biomarkers, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurological Biomarkers sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurological Biomarkers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neurological Biomarkers sales, projected growth trends, production technology, application and end-user industry.

Neurological Biomarkers Segment by Company

Thermo Fisher Scientific

Merck

Quest Diagnostics

Abbott

Roche

Illumina

Bio-Rad Laboratories

QIAGEN

Myriad RBM

Cisbio Bioassays

Athena Diagnostics

BGI

Wuxi APP

Aepodia

Proteome Sciences

Genewiz

Neurological Biomarkers Segment by Type

Proteomics

Genomics

Imaging

Bioinformatics

Others

Neurological Biomarkers Segment by Application

Diagnostics

Drug Discovery

Personalized Medicine

Others

Neurological Biomarkers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurological Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurological Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurological Biomarkers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neurological Biomarkers in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neurological Biomarkers manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurological Biomarkers sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neurological Biomarkers Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Proteomics Major Manufacturers Table 3. Genomics Major Manufacturers Table 4. Imaging Major Manufacturers Table 5. Bioinformatics Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Neurological Biomarkers Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Diagnostics Major Manufacturers Table 9. Drug Discovery Major Manufacturers Table 10. Personalized Medicine Major Manufacturers Table 11. Others Major Manufacturers Table 12. Neurological Biomarkers Industry Trends Table 13. Neurological Biomarkers Industry Drivers Table 14. Neurological Biomarkers Industry Opportunities and Challenges Table 15. Neurological Biomarkers Industry Restraints Table 16. Global Neurological Biomarkers Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Neurological Biomarkers Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Neurological Biomarkers Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Neurological Biomarkers Revenue Market Share by Region (2021-2026) Table 20. Global Neurological Biomarkers Revenue Market Share by Region (2027-2032) Table 21. Global Neurological Biomarkers Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Neurological Biomarkers Sales by Region (2021-2026) & (K Units) Table 23. Global Neurological Biomarkers Sales by Region (2027-2032) & (K Units) Table 24. Global Neurological Biomarkers Sales Market Share by Region (2021-2026) Table 25. Global Neurological Biomarkers Sales Market Share by Region (2027-2032) Table 26. Global Neurological Biomarkers Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Neurological Biomarkers Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Neurological Biomarkers Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Neurological Biomarkers Sales Market Share by Manufacturers (2021-2026) Table 30. Global Neurological Biomarkers Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 31. Global Neurological Biomarkers Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Neurological Biomarkers Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Neurological Biomarkers Manufacturers, Product Type & Application Table 34. Global Neurological Biomarkers Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Neurological Biomarkers by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Neurological Biomarkers Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Neurological Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Neurological Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Neurological Biomarkers Revenue Market Share by Type (2021-2026) Table 41. Global Neurological Biomarkers Revenue Market Share by Type (2027-2032) Table 42. Global Neurological Biomarkers Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 44. Global Neurological Biomarkers Sales by Type (2027-2032) & (K Units) Table 45. Global Neurological Biomarkers Sales Market Share by Type (2021-2026) Table 46. Global Neurological Biomarkers Sales Market Share by Type (2027-2032) Table 47. Global Neurological Biomarkers Price by Type (2021-2026) & (USD/Unit) Table 48. Global Neurological Biomarkers Price by Type (2027-2032) & (USD/Unit) Table 49. Global Neurological Biomarkers Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Neurological Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Neurological Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Neurological Biomarkers Revenue Market Share by Application (2021-2026) Table 53. Global Neurological Biomarkers Revenue Market Share by Application (2027-2032) Table 54. Global Neurological Biomarkers Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 56. Global Neurological Biomarkers Sales by Application (2027-2032) & (K Units) Table 57. Global Neurological Biomarkers Sales Market Share by Application (2021-2026) Table 58. Global Neurological Biomarkers Sales Market Share by Application (2027-2032) Table 59. Global Neurological Biomarkers Price by Application (2021-2026) & (USD/Unit) Table 60. Global Neurological Biomarkers Price by Application (2027-2032) & (USD/Unit) Table 61. Thermo Fisher Scientific Company Information Table 62. Thermo Fisher Scientific Business Overview Table 63. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 64. Thermo Fisher Scientific Neurological Biomarkers Product Portfolio Table 65. Thermo Fisher Scientific Recent Development Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Merck Neurological Biomarkers Product Portfolio Table 70. Merck Recent Development Table 71. Quest Diagnostics Company Information Table 72. Quest Diagnostics Business Overview Table 73. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Quest Diagnostics Neurological Biomarkers Product Portfolio Table 75. Quest Diagnostics Recent Development Table 76. Abbott Company Information Table 77. Abbott Business Overview Table 78. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Abbott Neurological Biomarkers Product Portfolio Table 80. Abbott Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Roche Neurological Biomarkers Product Portfolio Table 85. Roche Recent Development Table 86. Illumina Company Information Table 87. Illumina Business Overview Table 88. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Illumina Neurological Biomarkers Product Portfolio Table 90. Illumina Recent Development Table 91. Bio-Rad Laboratories Company Information Table 92. Bio-Rad Laboratories Business Overview Table 93. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Bio-Rad Laboratories Neurological Biomarkers Product Portfolio Table 95. Bio-Rad Laboratories Recent Development Table 96. QIAGEN Company Information Table 97. QIAGEN Business Overview Table 98. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. QIAGEN Neurological Biomarkers Product Portfolio Table 100. QIAGEN Recent Development Table 101. Myriad RBM Company Information Table 102. Myriad RBM Business Overview Table 103. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Myriad RBM Neurological Biomarkers Product Portfolio Table 105. Myriad RBM Recent Development Table 106. Cisbio Bioassays Company Information Table 107. Cisbio Bioassays Business Overview Table 108. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Cisbio Bioassays Neurological Biomarkers Product Portfolio Table 110. Cisbio Bioassays Recent Development Table 111. Athena Diagnostics Company Information Table 112. Athena Diagnostics Business Overview Table 113. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Athena Diagnostics Neurological Biomarkers Product Portfolio Table 115. Athena Diagnostics Recent Development Table 116. BGI Company Information Table 117. BGI Business Overview Table 118. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. BGI Neurological Biomarkers Product Portfolio Table 120. BGI Recent Development Table 121. Wuxi APP Company Information Table 122. Wuxi APP Business Overview Table 123. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Wuxi APP Neurological Biomarkers Product Portfolio Table 125. Wuxi APP Recent Development Table 126. Aepodia Company Information Table 127. Aepodia Business Overview Table 128. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Aepodia Neurological Biomarkers Product Portfolio Table 130. Aepodia Recent Development Table 131. Proteome Sciences Company Information Table 132. Proteome Sciences Business Overview Table 133. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Proteome Sciences Neurological Biomarkers Product Portfolio Table 135. Proteome Sciences Recent Development Table 136. Genewiz Company Information Table 137. Genewiz Business Overview Table 138. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Genewiz Neurological Biomarkers Product Portfolio Table 140. Genewiz Recent Development Table 141. North America Neurological Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 142. North America Neurological Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 143. North America Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 144. North America Neurological Biomarkers Sales by Type (2027-2032) & (K Units) Table 145. North America Neurological Biomarkers Sales Price by Type (2021-2026) & (USD/Unit) Table 146. North America Neurological Biomarkers Sales Price by Type (2027-2032) & (USD/Unit) Table 147. North America Neurological Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 148. North America Neurological Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 149. North America Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 150. North America Neurological Biomarkers Sales by Application (2027-2032) & (K Units) Table 151. North America Neurological Biomarkers Sales Price by Application (2021-2026) & (USD/Unit) Table 152. North America Neurological Biomarkers Sales Price by Application (2027-2032) & (USD/Unit) Table 153. North America Neurological Biomarkers Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Neurological Biomarkers Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. North America Neurological Biomarkers Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. North America Neurological Biomarkers Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 157. North America Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 158. North America Neurological Biomarkers Sales by Country (2027-2032) & (K Units) Table 159. North America Neurological Biomarkers Sales Price by Country (2021-2026) & (USD/Unit) Table 160. North America Neurological Biomarkers Sales Price by Country (2027-2032) & (USD/Unit) Table 161. United States Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 162. Canada Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 163. Mexico Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 164. Europe Neurological Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe Neurological Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 167. Europe Neurological Biomarkers Sales by Type (2027-2032) & (K Units) Table 168. Europe Neurological Biomarkers Sales Price by Type (2021-2026) & (USD/Unit) Table 169. Europe Neurological Biomarkers Sales Price by Type (2027-2032) & (USD/Unit) Table 170. Europe Neurological Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 171. Europe Neurological Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 172. Europe Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 173. Europe Neurological Biomarkers Sales by Application (2027-2032) & (K Units) Table 174. Europe Neurological Biomarkers Sales Price by Application (2021-2026) & (USD/Unit) Table 175. Europe Neurological Biomarkers Sales Price by Application (2027-2032) & (USD/Unit) Table 176. Europe Neurological Biomarkers Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Neurological Biomarkers Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Europe Neurological Biomarkers Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Europe Neurological Biomarkers Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Europe Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 181. Europe Neurological Biomarkers Sales by Country (2027-2032) & (K Units) Table 182. Europe Neurological Biomarkers Sales Price by Country (2021-2026) & (USD/Unit) Table 183. Europe Neurological Biomarkers Sales Price by Country (2027-2032) & (USD/Unit) Table 184. Germany Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 185. France Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 186. U.K. Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 187. Italy Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 188. Russia Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 189. Spain Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 190. Netherlands Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 191. Switzerland Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 192. Sweden Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 193. Poland Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 194. China Neurological Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 195. China Neurological Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 196. China Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 197. China Neurological Biomarkers Sales by Type (2027-2032) & (K Units) Table 198. China Neurological Biomarkers Sales Price by Type (2021-2026) & (USD/Unit) Table 199. China Neurological Biomarkers Sales Price by Type (2027-2032) & (USD/Unit) Table 200. China Neurological Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 201. China Neurological Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 202. China Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 203. China Neurological Biomarkers Sales by Application (2027-2032) & (K Units) Table 204. China Neurological Biomarkers Sales Price by Application (2021-2026) & (USD/Unit) Table 205. China Neurological Biomarkers Sales Price by Application (2027-2032) & (USD/Unit) Table 206. Asia Neurological Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 207. Asia Neurological Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 208. Asia Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 209. Asia Neurological Biomarkers Sales by Type (2027-2032) & (K Units) Table 210. Asia Neurological Biomarkers Sales Price by Type (2021-2026) & (USD/Unit) Table 211. Asia Neurological Biomarkers Sales Price by Type (2027-2032) & (USD/Unit) Table 212. Asia Neurological Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia Neurological Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 215. Asia Neurological Biomarkers Sales by Application (2027-2032) & (K Units) Table 216. Asia Neurological Biomarkers Sales Price by Application (2021-2026) & (USD/Unit) Table 217. Asia Neurological Biomarkers Sales Price by Application (2027-2032) & (USD/Unit) Table 218. Asia Neurological Biomarkers Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Asia Neurological Biomarkers Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Asia Neurological Biomarkers Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Asia Neurological Biomarkers Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. Asia Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 223. Asia Neurological Biomarkers Sales by Country (2027-2032) & (K Units) Table 224. Asia Neurological Biomarkers Sales Price by Country (2021-2026) & (USD/Unit) Table 225. Asia Neurological Biomarkers Sales Price by Country (2027-2032) & (USD/Unit) Table 226. Japan Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 227. South Korea Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 228. India Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 229. Australia Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 230. Taiwan Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 231. Southeast Asia Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 232. SAMEA Neurological Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA Neurological Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 235. SAMEA Neurological Biomarkers Sales by Type (2027-2032) & (K Units) Table 236. SAMEA Neurological Biomarkers Sales Price by Type (2021-2026) & (USD/Unit) Table 237. SAMEA Neurological Biomarkers Sales Price by Type (2027-2032) & (USD/Unit) Table 238. SAMEA Neurological Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 239. SAMEA Neurological Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 240. SAMEA Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 241. SAMEA Neurological Biomarkers Sales by Application (2027-2032) & (K Units) Table 242. SAMEA Neurological Biomarkers Sales Price by Application (2021-2026) & (USD/Unit) Table 243. SAMEA Neurological Biomarkers Sales Price by Application (2027-2032) & (USD/Unit) Table 244. SAMEA Neurological Biomarkers Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. SAMEA Neurological Biomarkers Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. SAMEA Neurological Biomarkers Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. SAMEA Neurological Biomarkers Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 248. SAMEA Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 249. SAMEA Neurological Biomarkers Sales by Country (2027-2032) & (K Units) Table 250. SAMEA Neurological Biomarkers Sales Price by Country (2021-2026) & (USD/Unit) Table 251. SAMEA Neurological Biomarkers Sales Price by Country (2027-2032) & (USD/Unit) Table 252. Brazil Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 253. Argentina Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 254. Chile Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 255. Colombia Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 256. Peru Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 257. Saudi Arabia Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 258. Israel Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 259. UAE Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 260. Turkey Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 261. Iran Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 262. Egypt Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Table 263. Key Raw Materials Table 264. Raw Materials Key Suppliers Table 265. Neurological Biomarkers Distributors List Table 266. Neurological Biomarkers Customers List Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. Neurological Biomarkers Image Figure 2. Global Neurological Biomarkers Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurological Biomarkers Market Size Share 2021 VS 2025 VS 2032 Figure 4. Proteomics Image Figure 5. Genomics Image Figure 6. Imaging Image Figure 7. Bioinformatics Image Figure 8. Others Image Figure 9. Global Neurological Biomarkers Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Neurological Biomarkers Market Size Share 2021 VS 2025 VS 2032 Figure 11. Diagnostics Image Figure 12. Drug Discovery Image Figure 13. Personalized Medicine Image Figure 14. Others Image Figure 15. Global Neurological Biomarkers Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Neurological Biomarkers Revenue (2021-2032) & (US$ Million) Figure 17. Global Neurological Biomarkers Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Neurological Biomarkers Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Neurological Biomarkers Revenue Market Share by Region (2021-2032) Figure 20. Global Neurological Biomarkers Sales (2021-2032) & (K Units) Figure 21. Global Neurological Biomarkers Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Neurological Biomarkers Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Neurological Biomarkers Sales YoY (2021-2032) & (K Units) Figure 24. Europe Neurological Biomarkers Sales YoY (2021-2032) & (K Units) Figure 25. China Neurological Biomarkers Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Neurological Biomarkers Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Neurological Biomarkers Sales YoY (2021-2032) & (K Units) Figure 28. Global Neurological Biomarkers Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Neurological Biomarkers Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Neurological Biomarkers Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Neurological Biomarkers Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Neurological Biomarkers Revenue Market Share by Type (2021-2032) Figure 34. Global Neurological Biomarkers Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Neurological Biomarkers Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Neurological Biomarkers Sales Market Share by Type (2021-2032) Figure 37. Global Neurological Biomarkers Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Neurological Biomarkers Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Neurological Biomarkers Revenue Market Share by Application (2021-2032) Figure 40. Global Neurological Biomarkers Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Neurological Biomarkers Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Neurological Biomarkers Sales Market Share by Application (2021-2032) Figure 43. North America Neurological Biomarkers Revenue Share by Type (2021-2032) Figure 44. North America Neurological Biomarkers Sales Share by Type (2021-2032) Figure 45. North America Neurological Biomarkers Revenue Share by Application (2021-2032) Figure 46. North America Neurological Biomarkers Sales Share by Application (2021-2032) Figure 47. North America Neurological Biomarkers Revenue Share by Country (2021-2032) Figure 48. North America Neurological Biomarkers Sales Share by Country (2021-2032) Figure 49. Europe Neurological Biomarkers Revenue Share by Type (2021-2032) Figure 50. Europe Neurological Biomarkers Sales Share by Type (2021-2032) Figure 51. Europe Neurological Biomarkers Revenue Share by Application (2021-2032) Figure 52. Europe Neurological Biomarkers Sales Share by Application (2021-2032) Figure 53. Europe Neurological Biomarkers Revenue Share by Country (2021-2032) Figure 54. Europe Neurological Biomarkers Sales Share by Country (2021-2032) Figure 55. China Neurological Biomarkers Revenue Share by Type (2021-2032) Figure 56. China Neurological Biomarkers Sales Share by Type (2021-2032) Figure 57. China Neurological Biomarkers Revenue Share by Application (2021-2032) Figure 58. China Neurological Biomarkers Sales Share by Application (2021-2032) Figure 59. Asia Neurological Biomarkers Revenue Share by Type (2021-2032) Figure 60. Asia Neurological Biomarkers Sales Share by Type (2021-2032) Figure 61. Asia Neurological Biomarkers Revenue Share by Application (2021-2032) Figure 62. Asia Neurological Biomarkers Sales Share by Application (2021-2032) Figure 63. Asia Neurological Biomarkers Revenue Share by Country (2021-2032) Figure 64. Asia Neurological Biomarkers Sales Share by Country (2021-2032) Figure 65. SAMEA Neurological Biomarkers Revenue Share by Type (2021-2032) Figure 66. SAMEA Neurological Biomarkers Sales Share by Type (2021-2032) Figure 67. SAMEA Neurological Biomarkers Revenue Share by Application (2021-2032) Figure 68. SAMEA Neurological Biomarkers Sales Share by Application (2021-2032) Figure 69. SAMEA Neurological Biomarkers Revenue Share by Country (2021-2032) Figure 70. SAMEA Neurological Biomarkers Sales Share by Country (2021-2032) Figure 71. Neurological Biomarkers Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Neurological Biomarkers Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Proteomics
  • Genomics
  • Imaging
  • Bioinformatics
  • Others
Applications
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Quest Diagnostics
  • Abbott
  • Roche
  • Illumina
  • Bio-Rad Laboratories
  • QIAGEN
  • Myriad RBM
  • Cisbio Bioassays
  • Athena Diagnostics
  • BGI
  • Wuxi APP
  • Aepodia
  • Proteome Sciences
  • Genewiz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neurological Biomarkers Market by Type
  3. 1.2.1 Global Neurological Biomarkers Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Proteomics
  5. 1.2.3 Genomics
  6. 1.2.4 Imaging
  7. 1.2.5 Bioinformatics
  8. 1.2.6 Others
  9. 1.3 Neurological Biomarkers Market by Application
  10. 1.3.1 Global Neurological Biomarkers Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Diagnostics
  12. 1.3.3 Drug Discovery
  13. 1.3.4 Personalized Medicine
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Neurological Biomarkers Market Dynamics
  1. 2.1 Neurological Biomarkers Industry Trends
  2. 2.2 Neurological Biomarkers Industry Drivers
  3. 2.3 Neurological Biomarkers Industry Opportunities and Challenges
  4. 2.4 Neurological Biomarkers Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neurological Biomarkers Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neurological Biomarkers Revenue by Region
  3. 3.2.1 Global Neurological Biomarkers Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neurological Biomarkers Revenue by Region (2021-2026)
  5. 3.2.3 Global Neurological Biomarkers Revenue by Region (2027-2032)
  6. 3.2.4 Global Neurological Biomarkers Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neurological Biomarkers Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neurological Biomarkers Sales by Region
  9. 3.4.1 Global Neurological Biomarkers Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neurological Biomarkers Sales by Region (2021-2026)
  11. 3.4.3 Global Neurological Biomarkers Sales by Region (2027-2032)
  12. 3.4.4 Global Neurological Biomarkers Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neurological Biomarkers Revenue by Manufacturers
  2. 4.1.1 Global Neurological Biomarkers Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neurological Biomarkers Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neurological Biomarkers Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neurological Biomarkers Sales by Manufacturers
  6. 4.2.1 Global Neurological Biomarkers Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neurological Biomarkers Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neurological Biomarkers Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neurological Biomarkers Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neurological Biomarkers Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neurological Biomarkers Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neurological Biomarkers Manufacturers, Product Type & Application
  13. 4.7 Global Neurological Biomarkers Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neurological Biomarkers Market CR5 and HHI
  16. 4.8.2 2025 Neurological Biomarkers Tier 1, Tier 2, and Tier 3
5 Neurological Biomarkers Market by Type
  1. 5.1 Global Neurological Biomarkers Revenue by Type
  2. 5.1.1 Global Neurological Biomarkers Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neurological Biomarkers Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neurological Biomarkers Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neurological Biomarkers Sales by Type
  6. 5.2.1 Global Neurological Biomarkers Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurological Biomarkers Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Neurological Biomarkers Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neurological Biomarkers Price by Type
6 Neurological Biomarkers Market by Application
  1. 6.1 Global Neurological Biomarkers Revenue by Application
  2. 6.1.1 Global Neurological Biomarkers Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neurological Biomarkers Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neurological Biomarkers Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neurological Biomarkers Sales by Application
  6. 6.2.1 Global Neurological Biomarkers Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neurological Biomarkers Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Neurological Biomarkers Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neurological Biomarkers Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Neurological Biomarkers Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Quest Diagnostics
  14. 7.3.1 Quest Diagnostics Company Information
  15. 7.3.2 Quest Diagnostics Business Overview
  16. 7.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Quest Diagnostics Neurological Biomarkers Product Portfolio
  18. 7.3.5 Quest Diagnostics Recent Developments
  19. 7.4 Abbott
  20. 7.4.1 Abbott Company Information
  21. 7.4.2 Abbott Business Overview
  22. 7.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Abbott Neurological Biomarkers Product Portfolio
  24. 7.4.5 Abbott Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Roche Neurological Biomarkers Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Illumina
  32. 7.6.1 Illumina Company Information
  33. 7.6.2 Illumina Business Overview
  34. 7.6.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Illumina Neurological Biomarkers Product Portfolio
  36. 7.6.5 Illumina Recent Developments
  37. 7.7 Bio-Rad Laboratories
  38. 7.7.1 Bio-Rad Laboratories Company Information
  39. 7.7.2 Bio-Rad Laboratories Business Overview
  40. 7.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Rad Laboratories Neurological Biomarkers Product Portfolio
  42. 7.7.5 Bio-Rad Laboratories Recent Developments
  43. 7.8 QIAGEN
  44. 7.8.1 QIAGEN Company Information
  45. 7.8.2 QIAGEN Business Overview
  46. 7.8.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 QIAGEN Neurological Biomarkers Product Portfolio
  48. 7.8.5 QIAGEN Recent Developments
  49. 7.9 Myriad RBM
  50. 7.9.1 Myriad RBM Company Information
  51. 7.9.2 Myriad RBM Business Overview
  52. 7.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Myriad RBM Neurological Biomarkers Product Portfolio
  54. 7.9.5 Myriad RBM Recent Developments
  55. 7.10 Cisbio Bioassays
  56. 7.10.1 Cisbio Bioassays Company Information
  57. 7.10.2 Cisbio Bioassays Business Overview
  58. 7.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cisbio Bioassays Neurological Biomarkers Product Portfolio
  60. 7.10.5 Cisbio Bioassays Recent Developments
  61. 7.11 Athena Diagnostics
  62. 7.11.1 Athena Diagnostics Company Information
  63. 7.11.2 Athena Diagnostics Business Overview
  64. 7.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Athena Diagnostics Neurological Biomarkers Product Portfolio
  66. 7.11.5 Athena Diagnostics Recent Developments
  67. 7.12 BGI
  68. 7.12.1 BGI Company Information
  69. 7.12.2 BGI Business Overview
  70. 7.12.3 BGI Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 BGI Neurological Biomarkers Product Portfolio
  72. 7.12.5 BGI Recent Developments
  73. 7.13 Wuxi APP
  74. 7.13.1 Wuxi APP Company Information
  75. 7.13.2 Wuxi APP Business Overview
  76. 7.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Wuxi APP Neurological Biomarkers Product Portfolio
  78. 7.13.5 Wuxi APP Recent Developments
  79. 7.14 Aepodia
  80. 7.14.1 Aepodia Company Information
  81. 7.14.2 Aepodia Business Overview
  82. 7.14.3 Aepodia Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Aepodia Neurological Biomarkers Product Portfolio
  84. 7.14.5 Aepodia Recent Developments
  85. 7.15 Proteome Sciences
  86. 7.15.1 Proteome Sciences Company Information
  87. 7.15.2 Proteome Sciences Business Overview
  88. 7.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Proteome Sciences Neurological Biomarkers Product Portfolio
  90. 7.15.5 Proteome Sciences Recent Developments
  91. 7.16 Genewiz
  92. 7.16.1 Genewiz Company Information
  93. 7.16.2 Genewiz Business Overview
  94. 7.16.3 Genewiz Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Genewiz Neurological Biomarkers Product Portfolio
  96. 7.16.5 Genewiz Recent Developments
8 North America
  1. 8.1 North America Neurological Biomarkers Market Size by Type
  2. 8.1.1 North America Neurological Biomarkers Revenue by Type (2021-2032)
  3. 8.1.2 North America Neurological Biomarkers Sales by Type (2021-2032)
  4. 8.1.3 North America Neurological Biomarkers Price by Type (2021-2032)
  5. 8.2 North America Neurological Biomarkers Market Size by Application
  6. 8.2.1 North America Neurological Biomarkers Revenue by Application (2021-2032)
  7. 8.2.2 North America Neurological Biomarkers Sales by Application (2021-2032)
  8. 8.2.3 North America Neurological Biomarkers Price by Application (2021-2032)
  9. 8.3 North America Neurological Biomarkers Market Size by Country
  10. 8.3.1 North America Neurological Biomarkers Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neurological Biomarkers Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neurological Biomarkers Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Neurological Biomarkers Market Size by Type
  2. 9.1.1 Europe Neurological Biomarkers Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neurological Biomarkers Sales by Type (2021-2032)
  4. 9.1.3 Europe Neurological Biomarkers Price by Type (2021-2032)
  5. 9.2 Europe Neurological Biomarkers Market Size by Application
  6. 9.2.1 Europe Neurological Biomarkers Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neurological Biomarkers Sales by Application (2021-2032)
  8. 9.2.3 Europe Neurological Biomarkers Price by Application (2021-2032)
  9. 9.3 Europe Neurological Biomarkers Market Size by Country
  10. 9.3.1 Europe Neurological Biomarkers Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neurological Biomarkers Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neurological Biomarkers Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Neurological Biomarkers Market Size by Type
  2. 10.1.1 China Neurological Biomarkers Revenue by Type (2021-2032)
  3. 10.1.2 China Neurological Biomarkers Sales by Type (2021-2032)
  4. 10.1.3 China Neurological Biomarkers Price by Type (2021-2032)
  5. 10.2 China Neurological Biomarkers Market Size by Application
  6. 10.2.1 China Neurological Biomarkers Revenue by Application (2021-2032)
  7. 10.2.2 China Neurological Biomarkers Sales by Application (2021-2032)
  8. 10.2.3 China Neurological Biomarkers Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neurological Biomarkers Market Size by Type
  2. 11.1.1 Asia Neurological Biomarkers Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neurological Biomarkers Sales by Type (2021-2032)
  4. 11.1.3 Asia Neurological Biomarkers Price by Type (2021-2032)
  5. 11.2 Asia Neurological Biomarkers Market Size by Application
  6. 11.2.1 Asia Neurological Biomarkers Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neurological Biomarkers Sales by Application (2021-2032)
  8. 11.2.3 Asia Neurological Biomarkers Price by Application (2021-2032)
  9. 11.3 Asia Neurological Biomarkers Market Size by Country
  10. 11.3.1 Asia Neurological Biomarkers Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neurological Biomarkers Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neurological Biomarkers Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neurological Biomarkers Market Size by Type
  2. 12.1.1 SAMEA Neurological Biomarkers Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neurological Biomarkers Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neurological Biomarkers Price by Type (2021-2032)
  5. 12.2 SAMEA Neurological Biomarkers Market Size by Application
  6. 12.2.1 SAMEA Neurological Biomarkers Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neurological Biomarkers Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neurological Biomarkers Price by Application (2021-2032)
  9. 12.3 SAMEA Neurological Biomarkers Market Size by Country
  10. 12.3.1 SAMEA Neurological Biomarkers Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neurological Biomarkers Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neurological Biomarkers Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neurological Biomarkers Value Chain Analysis
  2. 13.1.1 Neurological Biomarkers Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neurological Biomarkers Production Mode & Process
  6. 13.2 Neurological Biomarkers Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neurological Biomarkers Distributors
  9. 13.2.3 Neurological Biomarkers Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst